Marker Therapeutics, Inc. (MRKR)
1.43
+0.02
(+1.42%)
USD |
NASDAQ |
May 21, 16:00
1.44
+0.01
(+0.70%)
After-Hours: 19:59
Marker Therapeutics EPS Diluted (Quarterly) : -0.1646 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tenaya Therapeutics, Inc. | -0.0889 |
| Krystal Biotech, Inc. | 1.833 |
| Neurocrine Biosciences, Inc. | 1.914 |
| Agenus, Inc. | 1.023 |
| Curis, Inc. | -1.250 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.179M |
| Total Expenses (Quarterly) | 3.179M |
| Enterprise Value | 8.204M |
| Earnings Yield | -47.12% |
| Normalized Earnings Yield | -47.11 |